Tech Company Financing Transactions
KaliVir Immunotherapeutics Funding Round
Company K Partners, SV Investment and private investors participated in a $14 million Series A funding round for KaliVir Immunotherapeutics. The financing was announced on 8/19/2026.
Transaction Overview
Company Name
Announced On
8/19/2026
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series A
Investors
Company K Partners (Lead Investor)
Proceeds Purpose
The company intends to use the funds to support the ongoing clinical development of its lead program, VET3-TGI (including patient enrollment in the STEALTH-001 Phase 1/1b clinical trial in patients with advanced solid tumors), and for general corporate purposes.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
240 Alpha Drive
Pittsburgh, PA 15238
USA
Pittsburgh, PA 15238
USA
Phone
Website
Email Address
Overview
KALIVIR is a biopharmaceutical company founded in 2019 dedicated to developing systemically deliverable oncolytic virus immunotherapies. We design a new class of oncolytic virus immunotherapies that combine the natural ability of viruses to kill cancers cell with novel mechanisms to stimulate anti-tumor immunity, modify tumor environment and maximize targeted killing across all tumor types. Our mission is to ensure every cancer cell in patients can be killed with our viruses, and ultimately cure cancer in all cancer patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Helena Chaye
Chief Financial Officer
Schond Greenway
Chief Medical Officer
James Burke
Chief Scientific Officer
Stephen Thorne
Vice President
Paul Youm
VP - Bus. Development
Adina Pelusio
VP - Regulatory Affairs
Ursula Fritsch
Browse more venture capital transactions:
Prev: 8/19/2026: Queen One venture capital transaction
Next: 8/19/2026: Rillet venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs